TrialInvestigational new drugs2020
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors.
Lee S Rosen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled itcites it